NFE2L2 and neoplasm: In full agreement with the previous experiment (Fig. 2), there was no significant difference in tumor multiplicity (Fig. 9c, d) or burden (Fig. 9e) between WT and Nrf2-KO mice, confirming that the absence of functional Nrf2 neither accelerates nor inhibits tumor development in this model.